What is Endo-Systems?
Endo-Systems, LLC is at the forefront of non-invasive body contouring and cellulite treatment technology, primarily through its endermologie® offerings. Designed for beauty, health, and med-aesthetic professionals, the company's innovative solutions aim to empower businesses by enhancing their service portfolios and delivering rapid, effective total body results for clients. As a subsidiary of the globally recognized LPG Group, Endo-Systems benefits from extensive support and a comprehensive product line, catering to a diverse clientele across spas, medical practices, and wellness centers. Their flagship products, including the Cellu M6 Alliance and Mobi M6, are instrumental in driving significant financial growth for partners by boosting client satisfaction and fostering long-term retention.
How much funding has Endo-Systems raised?
Endo-Systems has raised a total of $68K across 1 funding round:
Debt
$68K
Debt (2021): $68K with participation from PPP
What's next for Endo-Systems?
With the recent influx of substantial expansion capital, Endo-Systems is strategically positioned for accelerated growth within the competitive med-aesthetic market. This investment is likely to fuel further research and development into advanced body contouring technologies, enhance marketing and sales initiatives to broaden market reach, and potentially expand its operational footprint. The company's focus on providing high-ROI solutions for professional partners suggests a continued emphasis on business development and client success, reinforcing its role as a key player in the beauty and wellness industry.
See full Endo-Systems company page
